Connect Biopharma Holdings Stock Price History

CNTB Stock  USD 1.11  0.03  2.78%   
If you're considering investing in Connect Stock, it is important to understand the factors that can impact its price. As of today, the current price of Connect Biopharma stands at 1.11, as last reported on the 4th of December, with the highest price reaching 1.12 and the lowest price hitting 0.98 during the day. At this point, Connect Biopharma is very risky. Connect Biopharma secures Sharpe Ratio (or Efficiency) of 0.0014, which signifies that the company had a 0.0014% return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Connect Biopharma Holdings, which you can use to evaluate the volatility of the firm. Please confirm Connect Biopharma's Risk Adjusted Performance of (0.05), standard deviation of 5.43, and Mean Deviation of 3.93 to double-check if the risk estimate we provide is consistent with the expected return of 0.0069%.
  
At present, Connect Biopharma's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 10.1 K, whereas Common Stock Shares Outstanding is forecasted to decline to about 43.5 M. . At present, Connect Biopharma's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price Earnings Ratio is forecasted to decline to (1.15). Connect Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0014

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsCNTB

Estimated Market Risk

 4.9
  actual daily
43
57% of assets are more volatile

Expected Return

 0.01
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.0
  actual daily
0
Most of other assets perform better
Based on monthly moving average Connect Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Connect Biopharma by adding Connect Biopharma to a well-diversified portfolio.
Price Book
0.5376
Enterprise Value Ebitda
0.1857
Price Sales
2.5317
Shares Float
14.8 M
Wall Street Target Price
7

Connect Biopharma Stock Price History Chart

There are several ways to analyze Connect Stock price data. The simplest method is using a basic Connect candlestick price chart, which shows Connect Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 3, 20241.47
Lowest PriceNovember 26, 20240.97

Connect Biopharma December 4, 2024 Stock Price Synopsis

Various analyses of Connect Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Connect Stock. It can be used to describe the percentage change in the price of Connect Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Connect Stock.
Connect Biopharma Price Rate Of Daily Change 1.03 
Connect Biopharma Price Daily Balance Of Power 0.21 
Connect Biopharma Price Action Indicator 0.08 

Connect Biopharma December 4, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Connect Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Connect Biopharma intraday prices and daily technical indicators to check the level of noise trading in Connect Stock and then apply it to test your longer-term investment strategies against Connect.

Connect Stock Price History Data

The price series of Connect Biopharma for the period between Thu, Sep 5, 2024 and Wed, Dec 4, 2024 has a statistical range of 0.63 with a coefficient of variation of 11.07. The prices are distributed with arithmetic mean of 1.21. The median price for the last 90 days is 1.22.
OpenHighLowCloseVolume
12/04/2024
 1.07  1.12  0.98  1.11 
12/03/2024 1.07  1.12  0.98  1.11  37,117 
12/02/2024 1.02  1.09  1.02  1.08  30,006 
11/29/2024 0.99  1.08  0.99  1.06  13,523 
11/27/2024 0.98  1.05  0.94  1.03  39,163 
11/26/2024 0.97  1.01  0.92  0.97  49,836 
11/25/2024 0.96  0.99  0.96  0.98  22,082 
11/22/2024 1.04  1.04  0.99  1.00  7,818 
11/21/2024 0.95  1.05  0.95  0.99  14,113 
11/20/2024 0.92  1.05  0.91  1.05  12,744 
11/19/2024 1.02  1.02  0.95  0.98  27,413 
11/18/2024 1.11  1.11  0.98  1.01  21,259 
11/15/2024 1.05  1.11  0.98  1.11  34,063 
11/14/2024 1.01  1.01  0.98  0.99  17,550 
11/13/2024 1.03  1.09  1.00  1.00  22,848 
11/12/2024 1.08  1.08  1.01  1.04  15,920 
11/11/2024 1.16  1.16  0.99  1.05  31,451 
11/08/2024 1.08  1.18  1.08  1.12  3,220 
11/07/2024 1.13  1.17  1.11  1.13  3,136 
11/06/2024 1.20  1.22  1.01  1.19  168,510 
11/05/2024 1.25  1.28  1.20  1.24  16,071 
11/04/2024 1.22  1.40  1.18  1.20  99,432 
11/01/2024 1.22  1.24  1.15  1.18  26,875 
10/31/2024 1.17  1.18  1.16  1.16  8,842 
10/30/2024 1.18  1.18  1.16  1.17  15,626 
10/29/2024 1.23  1.23  1.18  1.20  8,039 
10/28/2024 1.20  1.26  1.20  1.26  20,151 
10/25/2024 1.16  1.21  1.16  1.19  26,500 
10/24/2024 1.22  1.22  1.21  1.22  5,731 
10/23/2024 1.22  1.22  1.16  1.22  2,734 
10/22/2024 1.21  1.22  1.18  1.22  15,995 
10/21/2024 1.20  1.23  1.14  1.21  33,281 
10/18/2024 1.25  1.25  1.25  1.25  1,521 
10/17/2024 1.23  1.30  1.22  1.24  9,442 
10/16/2024 1.35  1.35  1.22  1.25  9,258 
10/15/2024 1.38  1.38  1.26  1.26  17,389 
10/14/2024 1.22  1.44  1.22  1.40  13,576 
10/11/2024 1.33  1.36  1.24  1.24  36,575 
10/10/2024 1.27  1.38  1.26  1.26  10,139 
10/09/2024 1.28  1.36  1.21  1.35  36,117 
10/08/2024 1.26  1.31  1.22  1.28  33,572 
10/07/2024 1.31  1.47  1.24  1.26  113,918 
10/04/2024 1.52  1.52  1.39  1.41  38,613 
10/03/2024 1.45  1.48  1.38  1.47  36,100 
10/02/2024 1.44  1.51  1.43  1.45  24,463 
10/01/2024 1.39  1.44  1.38  1.41  4,258 
09/30/2024 1.35  1.51  1.35  1.44  49,546 
09/27/2024 1.40  1.45  1.35  1.35  10,455 
09/26/2024 1.38  1.50  1.29  1.41  61,975 
09/25/2024 1.23  1.30  1.23  1.28  14,089 
09/24/2024 1.22  1.23  1.21  1.23  8,770 
09/23/2024 1.20  1.23  1.20  1.22  5,064 
09/20/2024 1.23  1.23  1.22  1.23  1,544 
09/19/2024 1.25  1.25  1.20  1.24  5,428 
09/18/2024 1.29  1.30  1.16  1.18  23,438 
09/17/2024 1.20  1.33  1.18  1.28  11,103 
09/16/2024 1.18  1.27  1.12  1.18  15,535 
09/13/2024 1.25  1.25  1.20  1.23  8,772 
09/12/2024 1.15  1.26  1.15  1.20  7,076 
09/11/2024 1.23  1.27  1.23  1.26  5,172 
09/10/2024 1.25  1.30  1.13  1.27  24,026 

About Connect Biopharma Stock history

Connect Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Connect is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Connect Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Connect Biopharma stock prices may prove useful in developing a viable investing in Connect Biopharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding55.1 M43.5 M
Net Loss-1.2 B-1.1 B

Connect Biopharma Quarterly Net Working Capital

96.71 Million

Connect Biopharma Stock Technical Analysis

Connect Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Connect Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Connect Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run CEOs Directory Now

   

CEOs Directory

Screen CEOs from public companies around the world
All  Next Launch Module

Connect Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Connect Biopharma's price direction in advance. Along with the technical and fundamental analysis of Connect Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Connect to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Connect Stock analysis

When running Connect Biopharma's price analysis, check to measure Connect Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Connect Biopharma is operating at the current time. Most of Connect Biopharma's value examination focuses on studying past and present price action to predict the probability of Connect Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Connect Biopharma's price. Additionally, you may evaluate how the addition of Connect Biopharma to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals